142 related articles for article (PubMed ID: 9371511)
1. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.
Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA
Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
[TBL] [Abstract][Full Text] [Related]
4. Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide.
Chatterjee S; Cheng MF; Berger SJ; Berger NA
Cancer Res; 1994 Aug; 54(16):4405-11. PubMed ID: 8044789
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
[TBL] [Abstract][Full Text] [Related]
6. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics.
Gaddameedhi S; Chatterjee S
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S61-6. PubMed ID: 20009298
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide.
Chatterjee S; Cheng MF; Berger RB; Berger SJ; Berger NA
Cancer Res; 1995 Feb; 55(4):868-73. PubMed ID: 7850801
[TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens.
Cheng MF; Chatterjee S; Berger NA
Oncol Res; 1994; 6(6):269-79. PubMed ID: 7865902
[TBL] [Abstract][Full Text] [Related]
9. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity.
Hirota H; Gosky D; Berger NA; Chatterjee S
Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894
[TBL] [Abstract][Full Text] [Related]
10. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
Seidenfeld J; Barnes D; Block AL; Erickson LC
Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of topoisomerase II alpha is caused by up-regulation of GRP78.
Gosky D; Chatterjee S
Biochem Biophys Res Commun; 2003 Jan; 300(2):327-32. PubMed ID: 12504087
[TBL] [Abstract][Full Text] [Related]
13. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F
Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
15. DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.
Ali-Osman F; Srivenugopal K; Berger MS; Stein DE
Anticancer Res; 1990; 10(3):677-82. PubMed ID: 2164350
[TBL] [Abstract][Full Text] [Related]
16. Decreased cell survival and DNA repair capacity after UVC irradiation in association with down-regulation of GRP78/BiP in human RSa cells.
Zhai L; Kita K; Wano C; Wu Y; Sugaya S; Suzuki N
Exp Cell Res; 2005 May; 305(2):244-52. PubMed ID: 15817150
[TBL] [Abstract][Full Text] [Related]
17. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
Pu QQ; Bezwoda WR
Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
[TBL] [Abstract][Full Text] [Related]
18. Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator.
Hwang JH; Kim JY; Cha MR; Ryoo IJ; Choo SJ; Cho SM; Tsukumo Y; Tomida A; Shin-Ya K; Hwang YI; Yoo ID; Park HR
J Cell Physiol; 2008 Apr; 215(1):243-50. PubMed ID: 17941090
[TBL] [Abstract][Full Text] [Related]
19. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
